Literature DB >> 20581844

An allosteric inhibitor of substrate recognition by the SCF(Cdc4) ubiquitin ligase.

Stephen Orlicky1, Xiaojing Tang, Victor Neduva, Nadine Elowe, Eric D Brown, Frank Sicheri, Mike Tyers.   

Abstract

The specificity of SCF ubiquitin ligase-mediated protein degradation is determined by F-box proteins. We identified a biplanar dicarboxylic acid compound, called SCF-I2, as an inhibitor of substrate recognition by the yeast F-box protein Cdc4 using a fluorescence polarization screen to monitor the displacement of a fluorescein-labeled phosphodegron peptide. SCF-I2 inhibits the binding and ubiquitination of full-length phosphorylated substrates by SCF(Cdc4). A co-crystal structure reveals that SCF-I2 inserts itself between the beta-strands of blades 5 and 6 of the WD40 propeller domain of Cdc4 at a site that is 25 A away from the substrate binding site. Long-range transmission of SCF-I2 interactions distorts the substrate binding pocket and impedes recognition of key determinants in the Cdc4 phosphodegron. Mutation of the SCF-I2 binding site abrogates its inhibitory effect and explains specificity in the allosteric inhibition mechanism. Mammalian WD40 domain proteins may exhibit similar allosteric responsiveness and hence represent an extensive class of druggable target.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581844      PMCID: PMC4445864          DOI: 10.1038/nbt.1646

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  30 in total

Review 1.  Beta propellers: structural rigidity and functional diversity.

Authors:  V Fülöp; D T Jones
Journal:  Curr Opin Struct Biol       Date:  1999-12       Impact factor: 6.809

Review 2.  Allosteric modulation of G protein-coupled receptors.

Authors:  Lauren T May; Katie Leach; Patrick M Sexton; Arthur Christopoulos
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

Review 3.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

4.  Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box proteincomplexes that regulate cell division and methionine biosynthesis in yeast.

Authors:  E E Patton; A R Willems; D Sa; L Kuras; D Thomas; K L Craig; M Tyers
Journal:  Genes Dev       Date:  1998-03-01       Impact factor: 11.361

Review 5.  Function and regulation of cullin-RING ubiquitin ligases.

Authors:  Matthew D Petroski; Raymond J Deshaies
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

6.  SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box.

Authors:  C Bai; P Sen; K Hofmann; L Ma; M Goebl; J W Harper; S J Elledge
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

Review 7.  A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin.

Authors:  Andrew R Willems; Michael Schwab; Mike Tyers
Journal:  Biochim Biophys Acta       Date:  2004-11-29

Review 8.  FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation.

Authors:  Markus Welcker; Bruce E Clurman
Journal:  Nat Rev Cancer       Date:  2008-02       Impact factor: 60.716

Review 9.  Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

Authors:  David Frescas; Michele Pagano
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

10.  Ancestral paralogs and pseudoparalogs and their role in the emergence of the eukaryotic cell.

Authors:  Kira S Makarova; Yuri I Wolf; Sergey L Mekhedov; Boris G Mirkin; Eugene V Koonin
Journal:  Nucleic Acids Res       Date:  2005-08-16       Impact factor: 16.971

View more
  83 in total

Review 1.  SCF ubiquitin ligase-targeted therapies.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Nat Rev Drug Discov       Date:  2014-11-14       Impact factor: 84.694

Review 2.  Twists and turns in ubiquitin-like protein conjugation cascades.

Authors:  Brenda A Schulman
Journal:  Protein Sci       Date:  2011-11-09       Impact factor: 6.725

3.  Inhibitors for E3 ubiquitin ligases.

Authors:  John R Lydeard; J Wade Harper
Journal:  Nat Biotechnol       Date:  2010-07       Impact factor: 54.908

4.  New twists on proteasome inhibitors.

Authors:  Jim Kling
Journal:  Nat Biotechnol       Date:  2010-12       Impact factor: 54.908

5.  A Comprehensive Study of Molecular Evolution at the Self-Incompatibility Locus of Rosaceae.

Authors:  Jahanshah Ashkani; D J G Rees
Journal:  J Mol Evol       Date:  2015-12-29       Impact factor: 2.395

6.  A Structure-Based Strategy for Engineering Selective Ubiquitin Variant Inhibitors of Skp1-Cul1-F-Box Ubiquitin Ligases.

Authors:  Maryna Gorelik; Noah Manczyk; Alevtina Pavlenco; Igor Kurinov; Sachdev S Sidhu; Frank Sicheri
Journal:  Structure       Date:  2018-07-19       Impact factor: 5.006

Review 7.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

8.  Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.

Authors:  Dongping Wei; Meredith A Morgan; Yi Sun
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

Review 9.  Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.

Authors:  Chuan-Ming Xie; Wenyi Wei; Yi Sun
Journal:  J Genet Genomics       Date:  2013-02-10       Impact factor: 4.275

10.  Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1α.

Authors:  Dennis L Buckley; Jeffrey L Gustafson; Inge Van Molle; Anke G Roth; Hyun Seop Tae; Peter C Gareiss; William L Jorgensen; Alessio Ciulli; Craig M Crews
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-12       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.